Tanvex Biopharma Inc.

Tanvex BioPharma, a biopharma manufacturer, offers a biosimilar pipeline for neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. TX01 & TX‑05 are Phase III completed; TX‑04 & TX‑16 are Phase I, creating growth prospects in the U.S. and Taiwan.

Headquarters: Taiwan (TWN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 200
HQ: George Town

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
6541	Tanvex Biopharma Inc. Cap: 13.6B	EQUITY	TAI	TWD	KYG8676P1037	Active	📈